bioAffinity Technologies
BIAFW
5 hedge funds and large institutions have $85K invested in bioAffinity Technologies in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0.09% more ownership
Funds ownership: 3.29% → 3.38% (+0.09%)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
26% less capital invested
Capital invested by funds: $115K → $85K (-$30.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$5.69K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$1.94K |
| 3 |
CS
Clear Street
New York
|
+$112 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.88K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$28 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $61.2K | – | +1 | +0% |
|
|
CS
2
Clear Street
New York
| $7.56K | +$112 | +300 | +1% |
|
|
WAM
3
Warberg Asset Management
Winnetka,
Illinois
| $7.39K | +$1.94K | +5,200 | +27% |
|
|
4
Citadel Advisors
Miami,
Florida
| $4.57K | +$5.69K | +15,237 | New |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $4.22K | -$4.88K | -13,071 | -48% |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$28 | -66 | Closed |
|
BIAFW Hedge Fund Activity: Q1 2023 in Review
5 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q1 2023, worth a combined $85K — down 26% from $115K a quarter earlier.
Fund positioning in BIAFW was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $5.69K. The largest seller was Susquehanna International Group, cutting an estimated $4.88K.
- 5 institutional investors held bioAffinity Technologies (BIAFW) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $85K of bioAffinity Technologies stock for Q1 2023, down 26% quarter-over-quarter.
- 1 fund opened new bioAffinity Technologies positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest bioAffinity Technologies buyer in Q1 2023 was Citadel Advisors, an estimated $5.69K added.
- The largest bioAffinity Technologies seller in Q1 2023 was Susquehanna International Group, an estimated $4.88K sold.
Based on aggregated 13F filings for Q1 2023.